Bevacizumab 400mg Concentrate For Solution For Infusion
Country: Kenya
Language: English
Source: Pharmacy and Poisons Board
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Bevacizumab
Available from:
CADILA HEALTHCARE LIMITED Zydus Tower, Satellite Cross Roads, Ahmedabad 380
ATC code:
L01XC07
INN (International Name):
Bevacizumab
Dosage:
400 mg
Pharmaceutical form:
Concentrate For Solution For Infusion
Administration route:
INTRAVENOUS
Manufactured by:
CADILA HEALTHCARE LTD SURVEY NO. 23, 25/P, 37, 40/P, 42 TO 47,
Therapeutic area:
bevacizumab
Product summary:
Shelf life: 24 months
Authorization status:
Registered - Valid
